Sandoz Challenges CMS Over Generic Drugs Misclassification
On April 11, Sandoz Inc., a key player in the pharmaceutical industry, filed a lawsuit against the Centers for Medicare & Medicaid Services (CMS). The case was presented in a federal court located in Washington, D.C. Sandoz’s complaint rests on the allegation that CMS dismissed an objection raised by the company concerning the classification of…